Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01526265 · ClinicalTrials.gov registry record · NA
Way to Quit - Comparative Efficacy, Acceptance and Effectiveness of Health Incentive Structures
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 2,185
- Enrollment target
NCT01526265: Completed NA study, sponsored by University of Pennsylvania.
NCT01526265 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 2,185 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01526265, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,185 participants
- Enrollment target
Study Summary
Using the NIH-funded Way to Health platform, the investigators will conduct this smoking cessation randomized controlled trial (RCT) among CVS employees. The investigators will be able to determine the comparative and absolute efficacy and effectiveness of 4 different incentive structures that are each grounded in behavioral economic principles. Additionally, the investigators will measure rates of and reasons for acceptance of each incentive structure, and examine participant characteristics that modify the efficacy and acceptance of different incentive structures.
Primary Outcome
The primary measure of smoking cessation will be prolonged abstinence for 6 months, which will be measured by salivary cotinine testing or by urinary anabasine testing (for those participants using nicotine replacement therapy). Saliva samples will be analyzed using semi-quantitative immunochromatographic assay test strips at the University of Pennsylvania. Urine samples will be analyzed using gas chromatography at the Associated Regional and University Pathologists (ARUP) Lab, at the University
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Individual Rewards
- BEHAVIORAL Fixed Deposits
- BEHAVIORAL Competitive Deposits (Pari-Mutuel)
- BEHAVIORAL Collaborative Rewards
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,185 participants |
| Start Date | 2012-02 |
| Est. Completion | 2015-11 |
| Phase | NA |
What the finished NCT01526265 record still lists
NCT01526265 is an interventional study that assigns participants to a tested intervention. Its 2,185 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% higher).
The record links to 0 conditions, and to 5 interventions - of which Usual Care is the first listed.
NCT01526265 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01526265 about?
NCT01526265 is a clinical study titled "Way to Quit - Comparative Efficacy, Acceptance and Effectiveness of Health Incentive Structures". Using the NIH-funded Way to Health platform, the investigators will conduct this smoking cessation randomized controlled trial (RCT) among CVS employees. The investigators will be able to determine the comparative and absolute efficacy and effectiveness of 4 different incentive structures that are e...
What is the current status of trial NCT01526265?
This trial is currently completed. It is a NA study. The enrollment target is 2,185 participants. The study started on 2012-02. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01526265?
The interventions under investigation include: Usual Care (BEHAVIORAL), Individual Rewards (BEHAVIORAL), Fixed Deposits (BEHAVIORAL), Competitive Deposits (Pari-Mutuel) (BEHAVIORAL), Collaborative Rewards (BEHAVIORAL).
Who is sponsoring clinical trial NCT01526265?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01526265's enrollment target sits among peer trials
2,185 49th of 2000 higher than 1,952 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05917652 · 2,183 participants
The Actuate-CBC Study
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia